Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease

Neurology
Eric R SiemersPatrick C May

Abstract

LY450139 dihydrate, a gamma-secretase inhibitor, was studied in a randomized, controlled trial of 70 patients with Alzheimer disease. Subjects were given 30 mg for 1 week followed by 40 mg for 5 weeks. Treatment was well tolerated. Abeta(1-40) in plasma decreased by 38.2%; in CSF, Abeta(1-40) decreased by 4.42 +/- 9.55% (p = not significant). Higher drug doses may result in additional decreases in plasma Abeta concentrations and a measurable decrease in CSF Abeta.

Citations

Jun 19, 2010·Archives of Neurology·Mary Sano
Apr 5, 2012·Archives of Neurology·Lawrence S Honig
Feb 16, 2010·Aging Clinical and Experimental Research·Francesco PanzaAlberto Pilotto
Nov 27, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Taisuke Tomita
Jun 28, 2011·Journal of Neurology·Daniela Galimberti, Elio Scarpini
Aug 12, 2009·Current Neurology and Neuroscience Reports·Judith Neugroschl, Mary Sano
Aug 25, 2006·Current Neurology and Neuroscience Reports·David S Knopman
Aug 25, 2006·Current Neurology and Neuroscience Reports·Eric R SiemersPatrick C May
Jun 11, 2008·Neuromolecular Medicine·Esther S OhStina M Fangmark Tucker
Jun 27, 2008·Molecular Neurobiology·Donna M Barten, Charles F Albright
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Randall J Bateman, William E Klunk
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Michael S Wolfe
Feb 5, 2010·Lancet Neurology·Bruno A Bergmans, Bart De Strooper
Aug 18, 2010·ACS Chemical Neuroscience·Corey R Hopkins
Mar 2, 2010·Nature Reviews. Drug Discovery·Adriano Aguzzi, Tracy O'Connor
Jan 22, 2013·Nature Reviews. Drug Discovery·Patricia C Fulkerson, Marc E Rothenberg
Feb 9, 2010·Nature Reviews. Neurology·Bart De StrooperTodd Golde
Jul 26, 2013·The New England Journal of Medicine·Rachelle S DoodyUNKNOWN Semagacestat Study Group
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
Jul 20, 2011·The Journal of Biological Chemistry·Annelie PamrénHelena Karlström
Feb 9, 2012·The Journal of Biological Chemistry·Ji-Yeun HurLars O Tjernberg
May 27, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Peter R MertensThomas Rauen
Nov 4, 2006·Science·Erik D Roberson, Lennart Mucke
Jan 14, 2010·Cancer Research·Hannah HarrisonRobert B Clarke
Jul 19, 2011·Therapeutic Advances in Neurological Disorders·Daniela Galimberti, Elio Scarpini
Mar 9, 2012·Journal of Translational Medicine·Alexandra Wendler, Martin Wehling
Nov 19, 2008·Journal of Neuroinflammation·Brian GiuntaJun Tan
Dec 12, 2012·Alzheimer's Research & Therapy·Walter J Lukiw
Dec 31, 2010·Alzheimer's Research & Therapy·Guriqbal S BasiDale Schenk
Jul 14, 2012·PloS One·Hiroko NagaoSetsuro Komiya

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.